BioSpace News Archive

DURECT Announces Patient Dosing in Phase 2a Trial of DUR-928 in Alcoholic Hepatitis

DURECT Corporation announced it has commenced patient dosing in a Phase 2a clinical trial of DUR-928 in patients with alcoholic hepatitis (AH).

April 25, 2018

·

5 min read

BioForest

Presenting the 8th Annual RealSelf 100: Recognizing Leading Doctors of Cosmetic and Aesthetic Medicine

RealSelf announced recipients of the 8th annual RealSelf 100.

April 25, 2018

·

1 min read

Pharm Country

Philips Avent uGrow App Gives Parents Peace-of-Mind with Immediate Video Access to Healthcare Providers

New parenthood is full of questions - especially as it relates to baby’s health and wellbeing.

April 25, 2018

·

3 min read

FDA

FDA Approval of ThinPrep® Integrated Imager Expands Automated Imaging for Pap Testing to More Labs

Hologic, Inc. announced that the United States Food and Drug Administration (FDA) has granted premarket approval (PMA) for the ThinPrep® Integrated Imager, which will make automated imaging of Pap tests more broadly available to laboratories and cytologists in the United States.

April 25, 2018

·

5 min read

Business

Henry Schein To Present At Four Investor Conferences In May

Henry Schein, Inc. announced today that the Company will present at four investor conferences in May:

April 25, 2018

·

2 min read

Beleave Confirms Receipt of Commitments to Fulfill $5,000,000 Private Placement

Beleave Inc. is pleased to announce that it has received binding commitments for total proceeds of $5,000,000 at a price of $1.75 per unit.

April 25, 2018

·

2 min read

Business

MyChelle® Dermaceuticals Captures Two Awards from Top Consumer Natural Lifestyle, Health and Beauty Magazines

MyChelle® Dermaceuticals has added two new honors to a growing list of accolades recognizing the company’s innovations in natural skin care.

April 25, 2018

·

2 min read

Business

ImmunoGen Appoints Blaine McKee as Executive Vice President and Chief Business Officer

ImmunoGen, Inc. is a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer

April 25, 2018

·

3 min read

Policy

BlinkBio, Inc. Announces Issuance of U.S. Patent No. 9,931,407 Covering the Company’s Broadly Enabling SiLinker and Payload Cassette Technologies

BlinkBio Inc. announced that the USPTO issued patent no. US 9,931,407 covering BlinkBio’s SiLinker and Payload Cassette technologies, primary components of the Company’s Tunable Drug Conjugate (TDC) Platform.

April 25, 2018

·

2 min read

Business

PersonaPanels Joins Nielsen Connected Partner Program with Tanjo Platform, Launching Novel AI-Driven Marketing Research

PersonaPanels announced that it has joined the Nielsen Connected Partner Program.

April 25, 2018

·

4 min read